PreemptiveAI

PreemptiveAI is at the cutting edge of healthcare technology, leveraging machine learning and deep learning to create a predictive large medical model. This model harnesses biomedical signals from smartphones and wearable devices, generating real-time predictions of health outcomes. By normalizing and continuously analyzing this data, PreemptiveAI aims to revolutionize healthcare delivery, making it more efficient, cost-effective, and personalized. The company, led by CEO Jamien McCullum, is committed to reshaping the healthcare industry through innovative solutions that span from early disease detection to personalized treatment plans.

The foundation model of PreemptiveAI is a large-scale machine learning model trained on a broad dataset of human physiology and pathology. Its adaptability allows fine-tuning for various healthcare applications. This versatility positions PreemptiveAI as a pivotal tool in predictive analysis, drug development, and resource optimization for healthcare providers, pharmaceutical companies, and insurance payors alike.